- ClearBridge Select Strategy outperformed with a return of 10.7% compared to the return of 8.1% for the S&P 500 Index and 8.2% for the Russell 3000 Index.
- In Q3 2025, the fund initiated new positions in Regeneron Pharmaceuticals (NASDAQ:
ClearBridge Select buys REGN, VRTX & VST; exits ICLR, PCTY & ADBE

